Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asclepius Meditec is a leading Chinese medical technology company specializing in the development and manufacturing of high-precision neurosurgical robotic systems. The company's flagship product, the Remebot, is a stereotactic surgical robot designed to assist surgeons in performing minimally invasive neurosurgical procedures with enhanced accuracy and safety. By integrating advanced medical imaging, robotic control, and navigation software, Asclepius Meditec provides solutions for treating complex neurological conditions such as epilepsy, Parkinson's disease, and intracranial tumors. The company is at the forefront of the surgical robotics industry in Asia, focusing on improving clinical outcomes through technological innovation in the operating room.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Asclepius.